343 related articles for article (PubMed ID: 31071439)
1. Evaluation of miscibility and polymorphism of synthetic and natural lipids for nanostructured lipid carrier (NLC) formulations by Raman mapping and multivariate curve resolution (MCR).
Mitsutake H; Ribeiro LNM; Rodrigues da Silva GH; Castro SR; de Paula E; Poppi RJ; Breitkreitz MC
Eur J Pharm Sci; 2019 Jul; 135():51-59. PubMed ID: 31071439
[TBL] [Abstract][Full Text] [Related]
2. Natural lipids-based NLC containing lidocaine: from pre-formulation to in vivo studies.
Ribeiro LNM; Breitkreitz MC; Guilherme VA; da Silva GHR; Couto VM; Castro SR; de Paula BO; Machado D; de Paula E
Eur J Pharm Sci; 2017 Aug; 106():102-112. PubMed ID: 28558981
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different chemometric methods to extract chemical and physical information from Raman images of homogeneous and heterogeneous semi-solid pharmaceutical formulations.
Mitsutake H; Castro SR; de Paula E; Poppi RJ; Rutledge DN; Breitkreitz MC
Int J Pharm; 2018 Dec; 552(1-2):119-129. PubMed ID: 30266516
[TBL] [Abstract][Full Text] [Related]
4. Selection and characterization of suitable lipid excipients for use in the manufacture of didanosine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
Kasongo KW; Pardeike J; Müller RH; Walker RB
J Pharm Sci; 2011 Dec; 100(12):5185-96. PubMed ID: 22020815
[TBL] [Abstract][Full Text] [Related]
5. Bupivacaine (S75:R25) Loaded in Nanostructured Lipid Carriers: Factorial Design, HPLC Quantification Method and Physicochemical Stability Study.
Da Silva GHR; de Morais Ribeiro LN; Guilherme VA; de Castro SR; Breitkreitz MC; de Paula E
Curr Drug Deliv; 2018; 15(3):388-396. PubMed ID: 28745230
[TBL] [Abstract][Full Text] [Related]
6. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy.
Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L
Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015
[TBL] [Abstract][Full Text] [Related]
7. Effect of drug solubility and lipid carrier on drug release from lipid nanoparticles for dermal delivery.
Zoubari G; Staufenbiel S; Volz P; Alexiev U; Bodmeier R
Eur J Pharm Biopharm; 2017 Jan; 110():39-46. PubMed ID: 27810471
[TBL] [Abstract][Full Text] [Related]
8. Nanostructured lipid carriers (NLC) on the basis of Siberian pine (Pinus sibirica) seed oil.
Averina ES; Seewald G; Müller RH; Radnaeva LD; Popov DV
Pharmazie; 2010 Jan; 65(1):25-31. PubMed ID: 20187575
[TBL] [Abstract][Full Text] [Related]
9. Digestion of lipid excipients and lipid-based nanocarriers by pancreatic lipase and pancreatin.
Zöller K; To D; Knoll P; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2022 Jul; 176():32-42. PubMed ID: 35584719
[TBL] [Abstract][Full Text] [Related]
10. Cetyl palmitate-based NLC for topical delivery of Coenzyme Q(10) - development, physicochemical characterization and in vitro release studies.
Teeranachaideekul V; Souto EB; Junyaprasert VB; Müller RH
Eur J Pharm Biopharm; 2007 Aug; 67(1):141-8. PubMed ID: 17346953
[TBL] [Abstract][Full Text] [Related]
11. Formulation and characterization of novel nanostructured lipid carriers made from beeswax, propolis wax and pomegranate seed oil.
Soleimanian Y; Goli SAH; Varshosaz J; Sahafi SM
Food Chem; 2018 Apr; 244():83-92. PubMed ID: 29120809
[TBL] [Abstract][Full Text] [Related]
12. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
Martins S; Tho I; Souto E; Ferreira D; Brandl M
Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538
[TBL] [Abstract][Full Text] [Related]
13. Development of an itraconazole-loaded nanostructured lipid carrier (NLC) formulation for pulmonary application.
Pardeike J; Weber S; Haber T; Wagner J; Zarfl HP; Plank H; Zimmer A
Int J Pharm; 2011 Oct; 419(1-2):329-38. PubMed ID: 21839157
[TBL] [Abstract][Full Text] [Related]
14. Drug-Lipid-Surfactant Miscibility for the Development of Solid Lipid Nanoparticles.
Trivino A; Gumireddy A; Chauhan H
AAPS PharmSciTech; 2019 Jan; 20(2):46. PubMed ID: 30617602
[TBL] [Abstract][Full Text] [Related]
15. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
[TBL] [Abstract][Full Text] [Related]
16. Key production parameters for the development of solid lipid nanoparticles by high shear homogenization.
Souto EB; Doktorovova S; Zielinska A; Silva AM
Pharm Dev Technol; 2019 Nov; 24(9):1181-1185. PubMed ID: 31354002
[TBL] [Abstract][Full Text] [Related]
17. Nanostructured lipid carriers as semisolid topical delivery formulations for diflucortolone valerate.
Abdel-Salam FS; Mahmoud AA; Ammar HO; Elkheshen SA
J Liposome Res; 2017 Mar; 27(1):41-55. PubMed ID: 26956098
[TBL] [Abstract][Full Text] [Related]
18. Electron Paramagnetic Resonance and Small-Angle X-ray Scattering Characterization of Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Dibucaine Encapsulation.
Barbosa RM; Casadei BR; Duarte EL; Severino P; Barbosa LRS; Duran N; de Paula E
Langmuir; 2018 Nov; 34(44):13296-13304. PubMed ID: 30299102
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Miscibility of Novel Cocoa Butter Equivalents by Raman Mapping and Multivariate Curve Resolution-Alternating Least Squares.
Castro-Alayo EM; Torrejón-Valqui L; Cayo-Colca IS; Cárdenas-Toro FP
Foods; 2021 Dec; 10(12):. PubMed ID: 34945652
[TBL] [Abstract][Full Text] [Related]
20. Amphotericin B loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): physicochemical and solid-solution state characterizations.
Jansook P; Fülöp Z; Ritthidej GC
Drug Dev Ind Pharm; 2019 Apr; 45(4):560-567. PubMed ID: 30632399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
